Cargo Therapeutics, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
Samsara BioCapital, L.P., along with its general partner and managing member, Srinivas Akkaraju, reported a complete divestment of their beneficial ownership in Cargo Therapeutics, Inc. common stock.
Nextech VII GP S.a. r.l. and affiliated entities report zero beneficial ownership in Cargo Therapeutics, Inc. common stock, indicating a full divestment from their previously reported stake.
Madison Avenue Partners and affiliated entities have filed an amended Schedule 13G, indicating they no longer beneficially own any shares of CARGO Therapeutics, Inc.
RTW Investments, LP and Roderick Wong, M.D. have reported a 0.0% beneficial ownership in Cargo Therapeutics, Inc. common stock.
A group of investment entities led by Eli Samaha has reported a 9.1% passive ownership stake in CARGO Therapeutics, Inc., holding over 4.19 million shares.
RTW Investments and Roderick Wong have disclosed a 6.4% beneficial ownership stake in Cargo Therapeutics, Inc., holding over 3 million shares.
FMR LLC and Abigail P. Johnson reported a 0.0% beneficial ownership stake in Cargo Therapeutics Inc. common stock as of July 31, 2025.
FMR LLC and Abigail P. Johnson have disclosed a 15.0% beneficial ownership stake in Cargo Therapeutics Inc., holding 6,916,945 shares of common stock as of June 30, 2025.
Cormorant Asset Management, LP and Bihua Chen have disclosed a 7.33% beneficial ownership stake in CARGO Therapeutics, Inc., holding 3,381,277 shares of common stock.
T. Rowe Price Associates, Inc. has filed an amended Schedule 13G, disclosing a 1.3% beneficial ownership stake in CARGO THERAPEUTICS INC as of March 31, 2025.
SCHEDULE 13G/A: Janus Henderson Group PLC Amends Stake in Cargo Therapeutics, Reports 0.0% Ownership
Janus Henderson Group PLC has filed an amendment to its Schedule 13G, disclosing a beneficial ownership of 7,900 shares, representing 0.0% of Cargo Therapeutics, Inc.'s common stock.
SCHEDULE 13G/A: FMR LLC and Abigail P. Johnson Maintain Significant 11.3% Passive Stake in Cargo Therapeutics Inc.
FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, confirming their passive beneficial ownership of 11.3% of Cargo Therapeutics Inc.'s common stock as of March 31, 2025.
A group of investment entities led by Madison Avenue Partners LP and Eli Samaha have disclosed a passive 6.8% beneficial ownership stake in CARGO Therapeutics, Inc. common stock.
SCHEDULE 13G/A: Perceptive Advisors and Affiliates Disclose 2.5% Passive Stake in CARGO Therapeutics
Perceptive Advisors LLC, Joseph Edelman, and Perceptive Xontogeny Venture Fund II, L.P. collectively reported a 2.5% beneficial ownership stake in CARGO Therapeutics, Inc. common stock as of April 23, 2025.
Janus Henderson Group plc has filed an amended Schedule 13G, reporting a 6.2% beneficial ownership stake in CARGO Therapeutics, Inc. as of December 31, 2024.